Selected Reading
Abramovich MN, Toner ES, Matheny J. Panalysis: a new spreadsheet-based tool for pandemic planning. Biosecur Bioterror 2008 Mar;6(1):78-92
Acambis. Acambis enters flu vaccine arena with launch of flu vaccine development programme. Aug 4, 2005
ACEP (American College of Emergency Physicians). The national report card on the state of emergency medicine: evaluating the environment of emergency care systems state by state. Jan 2006
ACLU (American Civil Liberties Union). Pandemic preparedness: the need for a public health--not a law enforcement/national security--approach. Jan 14, 2008
ACP. The health care response to pandemic influenza. Position paper from the American College of Physicians. 2006
Albright FS, Orlando P, Pavia AT, et al. Evidence for a heritable predisposition to death due to influenza. J Infect Dis 2008 Jan;197 (published online Dec 11, 2007)
Alexander ME, Bowman CS, Feng Z, et al. Emergence of drug resistance: implications for antiviral control of pandemic influenza. Proc R Soc B 2007 (published online May 16)
Alford RH, Kasel JA, Gerone PJ, et al. Human influenza resulting from aerosol inhalation. Proc Soc Exp Biol Med 1966 Jul;122(3):800-4
American Council on Science and Health. Avian influenza, or bird flu: what you need to know. Mar 2006
Andreasen V, Viboud C, Simonsen l. Epidemiologic characterization of the 1918 pandemic summer wave in Copenhagen: implications for pandemic control strategies. J Infect Dis 2008 Jan 15;192(2):270-8
APHA (American Public Health Association). APHA's prescription for pandemic flu. Released Feb 22, 2007
Apisarnthanarak A, Warren DK, Fraser VJ. Issues relevant to the adoption and modification of hospital infection-control recommendations for avian influenza (H5N1 infection) in developing countries. Clin Infect Dis 2007 Nov 15;45(10):1338-42
Arinaminpathy N, McLean AR. Antiviral treatment for the control of pandemic influenza: some logistical constraints. J R Soc Interface 2007 (published online Aug 28)
Arizona Department of Health Services. Modern Methods for Influenza Detection and Sub-typing
ASTHO. Nature's terrorist attack: pandemic influenza. Preparedness planning for state health officials
ASTHO. Pandemic influenza: preparedness planning for state health officials. Nov 2002
Atmar RL, Keitel WA, Patel SM, et al. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. Clin Infect Dis 2006 Nov 1;43(9):1135?42
Auewarakul P, Suptawiwat O, Kongchanagul A, et al. An avian influenza H5N1 virus that binds to a human-type receptor. J Virol 2007 Sep;81(18):9950-5
Australian Department of Health and Ageing. National pandemic influenza exercise: Exercise Cumpston 06 report. Released Jun 7, 2007
Ayora-Talavera G, Cadavieco-Burgos JM, Canul-Armas AB. Serologic evidence of human and swine influenza. Emerg Infect Dis 2005 Jan;11(1):158-60
Balicer RD, Huerta M, Davidovitch N, et al. Cost-benefit of stockpiling drugs for influenza pandemic. Emerg Infect Dis 2005 Aug;11(8)
Balicer RD, Omer SB, Barnett SB, et al. Local public health workers' perceptions toward responding to an influenza pandemic. BMC Pub Health 2006 (Published online Apr 18)
Baras B, Stittelaar KJ, Simon JH, et al. Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine. PLoS ONE 2008 Jan 2;3(1):e1401
Barnett DJ, Balicer RD, Lucey DR, et al. A systematic analytic approach to pandemic influenza preparedness planning. PLoS Med 2005 Dec;2(12)
Barrett R, Brown PJ. Stigma in the time of influenza: social and institutional responses to pandemic emergencies. J Infect Dis 2008 Feb 15;197(S1):S34-7
Barry JM. 1918 revisited: lessons and suggestions for further inquiry. In: The threat of pandemic influenza: are we ready? Institute of Medicine. Nov 16, 2004
Barry JM. Nonpharmaceutical interventions implemented during the 1918-1919 influenza pandemic. (Letter) JAMA 2007 Nov 21;298(19):2260-1
Bartlett JG, Borio L. The current status of planning for pandemic influenza and implications for health care planning in the United States. Clin Infect Dis 2008;46 (published online Feb 14)
Bartlett JG. Planning for avian influenza. Ann Intern Med 2006 Jul 18;145(2) (published online Jun 27)
Baylor NW. Regulatory issues: pandemic preparedness pacing up. BioPharm Int 2007 Aug (supp) (published online Aug 2)
Bean B, Moore BM, Sterner B, at al. Survival of influenza viruses on environmental surfaces. J Infect Dis 1982 Jul;146(1):47-51
Beaton R, Stergachis A, Thompson J, et al. Pandemic policy and planning considerations for universities: findings from a tabletop exercise. Biosecur Bioterror 2007 Dec;5(4):327-34
Beaumont M, Duggal HV, Mahmood H, et al. A survey of the preparedness for an influenza pandemic of general practitioners in the West Midlands, UK. Eur J Clin Microbiol Infect Dis 2007 (published online Aug 10)
Beigel J, Bray M. Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res 2008 Apr;78(1):91-102
Belser JA, Lu X, Szretter KJ, et al. DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection. J Infect Dis 2007 Nov 15;196(10):1493-9
Belshe RB. The origins of pandemic influenza: lessons from the 1918 virus. N Engl J Med 2005 Nov 24;353(21):2209-11
Blendon RJ, Koonin LM, Benson JM, et al. Public response to community mitigation measures for pandemic influenza. Emerg Infect Dis 2008 May (published online Mar 28)
Blue Ribbon Commission on Mega-Catastrophes. Preparing for pandemic flu: a call to action. From Financial Services Roundtable. Nov 1, 2006
Blumenshine P, Reingold A, Egerter S, et al. Pandemic influenza planning in the United States from a health disparities perspective. Emerg Infect Dis 2008 May (published online Mar 28)
Bogner P, Capua I, Cox, NJ, et al. A global initiative on sharing avian flu data. Nature 2006 (Published online Aug 24)
Bootsma CJ, Ferguson NM. The effect of public health measures on the 1918 influenza pandemic in US cities. Proc Natl Acad Sci 2007 (published online Apr 6)
Booy R, Brown LE, Grohmann GS, et al. Pandemic vaccines: promises and pitfalls. Med J Aust 2006 Nov 20;185(10 suppl):S62-5
Bose ME, Littrell JC, Patzer AD, et al. The influenza primer design resource: a new tool for translating influenza sequence data into effective diagnostics. Influenza Other Resp Viruses 2008 Jan;2(1):23-31
Boyd M, Clezy K, Lindley R, et al. Pandemic influenza: clinical issues. Med J Aust 2006 Nov 20;185(10 suppl):S44-7
Brankston G, Gitterman L, Hirji A, et al. Transmission of influenza A in human beings. Lancet Infect Dis 2007, published online Feb 19
Branson RD, Johannigman JA, Daugherty EL, et al. Surge capacity mechanical ventilation. Respir Care 2008 Jan;53(1):78-90
Breiman RF, Nasidi A, Katz MA, et al. Preparedness for highly pathogenic avian influenza pandemic in Africa. (Perspective) Emerg Infect Dis 2007 Oct:13(10):1453-8
Brett AS, Zuger A. The run on Tamiflu: should physicians prescribe on demand? (Perspective) N Engl J Med 2005 Dec 22;353(24):2636-7
Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in healthcare settings. Clin Infect Dis 2003 Oct 15;37(8):1094-101
Bright RA, Carter DM, Crevar CJ, et al. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS ONE 2008 Jan 30;3(1):e1501
Brownstein JS, Wolfe CJ, Mandl KD. Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States. PLoS Med 2006 Oct;3(10)
Brownstein JS, Wolfe CJ, Mandl KD. Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States. PLoS Med 2006 Oct;3(10):e401
Brundage JF. Cases and deaths during influenza pandemics in the United States. Am J Prev Med 2006 Sep;31(3):252-6
Brundage JF. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis 2006 May;6(5):303-12
Buchholz U, Altmann D, Sagebiel D, et al. Stockpiling of anti-influenza drugs in private households: a survey in Germany. Eurosurveillance Weekly 2007 Jan 25;12(1):E070125.4
Buehler JW, Craig AS, Del Rio C, et al. Critical issues in responding to pandemic influenza. (Conference Summary) Emerg Infect Dis 2006 Jul;12(7)
Bui HH, Peters B, Assarsson E, et al. Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci 2007 Jan 2;104(1):246-51
Caley P, Becker NG, Philp DJ. The waiting time for inter-country spread of pandemic influenza. PLoS One 2007 Jan;2(1):e143
Caley P, Philp DJ, McCracken K. Quantifying social distancing arising from pandemic influenza. J R Soc Interface 2007 (published online Oct 4)
California Association of Health Facilities (CAHF). Pandemic influenza workbook for long term care providers. Aug 2007
Call SA, Vollenweider MA, Hornung CA, et al. Does this patient have influenza? JAMA 2005 Feb 23;293(8):987-97
Camitz M, Liljeros F. The effect of travel restrictions on the spread of a moderately contagious disease. BMC Med 2006;4(32) (published online Dec 14)
Campbell JD. Pandemic flu vaccine: are we doing enough? Clin Pharmacol Ther 2007 Dec;82(6):633-5
Capua I, Alexander DJ. Avian influenza: recent developments. Avian Pathol 2004 Aug;33(4):393-404
Carrat F, Luong J, Lao H, et al. A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics. BMC Med 2006;4(26) (published online Oct 23)
Cauchemez S, Valleron AJ, Boelle PY, et al. Estimating the impact of school closure on influenza transmission from Sentinel data. Nature 2008 Apr 10;452(7188):750-4
CDC. A commentary on the JAMA study's interpretation of the influenza experiences in New York City and Chicago, 1918-19. Jan 17, 2008
CDC. CDC influenza pandemic operation plan (OPLAN). Released Dec 20, 2006
CDC. Increased antiviral medication sales before the 2005-06 influenza season: New York City. MMWR 2006 Mar 17;55(10):277-9
CDC. Interim CDC-NIH recommendation for raising the biosafety level for laboratory work involving noncontemporary human influenza (H2N2) viruses. Excerpted from draft: Biosafety in microbiological and biomedical laboratories. Ed 5. May 3, 2005
CDC. Interim guidance for airline flight crews and persons meeeting passengers arriving from areas with avian influenza. Published Feb 18, 2004; updated frequently
CDC. Interim pre-pandemic planning guidance: community strategy for pandemic influenza mitigation in the United States--early, targeted, layered use of nonpharmaceutical interventions. Released Feb 1, 2007
CDC. Interim public health guidance for the use of facemasks and respirators in non-occupational community settings during an influenza pandemic. Released May 3, 2007
CDC. Interim recommendations for infection control in health-care facilities caring for patients with known or suspected avian influenza
CDC. Lab diagnosis.
CDC. New laboratory assay for diagnostic testing of avian influenza A/H5 (Asian lineage). MMWR 2006 Feb 3;55(Early release):1
CDC. Pandemic influenza: progress made and challenges ahead. Jan 24, 2007, statement by Director Julie L. Gerberding, MD, MPH, before US Senate subcommittee
CDC. Public health preparedness: mobilizing state by state. Feb 20, 2008
CDC. Q & A on Executive Order adding potentially pandemic influenza viruses to list of quarantinable diseases. Apr 11, 2005
CDC. Respiratory hygiene/cough etiquette in healthcare settings
CDC. Select Agent Program
CDC. Update on influenza A(H5N1) and SARS: Interim recommendations for enhanced U.S. surveillance, testing, and infection controls
CDC. Updated interim guidance for laboratory testing of persons with suspected infection with avian influenza A (H5N1) virus in the United States. Jun 7, 2006
CDC. What you should know about using facemasks and respirators during a flu pandemic. Released May 3, 2007
CDC/HICPAC. Guideline for isolation precautions in hospitals, 1994
CDC/HICPAC. Guidelines for Preventing Healthcare Associated Pneumonia, 2003
Chamberlain A, Gronvall GK. Immune-boosting adjuvants. Biosecur Bioterror 2007 Sep;5(3):202-5
Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005 Nov 11;6(1)
Chen GW, Chang SC, Mok CK, et al. Genomic signatures of human versus avian influenza A viruses. Emerg Infect Dis 2006 Sep;12(9):1353-60
Chen H, Smith GJ, Li KS, et al. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci 2006 (published online Feb 10)
Chen H, Subbarao K, Swayne D, et al. Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate. Vaccine 2003 May 16;21(17-18):1983-8
Chen J, Chen SCY, Stern P, et al. Genetic strategy to prevent influenza virus infections in animals. J Infect Dis 2008 Feb 15;197(S1):S25-8
Cheng X, Wu C, He J, et al. Serological and genetic characterization analyses of a highly pathogenic influenza virus (H5N1) islolated from an infected man in Shenzhen. J Med Virol 2008 Apr 21;80(6):1058-64
Chesser A, Ablah E, Hawley SR, et al. Preparedness needs assessment in a rural state: themes derived from public focus groups. Biosecur Bioterror 2006 Dec;4(4):376-83
Choi YK, Ozaki H, Webby RJ, et al. Continuing evolution of H9N2 influenza viruses in southeastern China. J Virol 2004 Aug;78(16):8609-14
Chowell G, Bettencourt LMA, Johnson N, et al. The 1918-1919 influenza pandemic in England and Wales: spatial patterns in transmissibility and mortality impact. Proc R Soc B 2007 (published online Dec 20)
Chowell G, Nishiura H, Bettencourt LMA. Comparative estimation of the reproduction number for pandemic influenza from daily case notification data. J R Soc Interface 2006 (published online Oct 12)
Christian MD, Hawryluck L, Wax RS, et al. Development of a triage protocol for critical care during an influenza pandemic. CMAJ 2006 Nov 21;175(11):1377-81
Christophersen OA, Haug A. Why is the world so poorly prepared for a pandemic of hypervirulent avian influenza? Microb Ecol Health Dis 2006 Dec;18(3-4):113-32
Chutinimitkul S, Songserm T, Amonsin A, et al. New strain of influenza A virus (H5N1), Thailand. (Letter) Emerg Infect Dis 2007 Mar;13(3) (published online Feb 15)
Coiras MT, Perez-Brena P, Garcia ML, et al. Simultaneous detection of influenza A, B, and C viruses, respiratory syncytial virus, and adenoviruses in clinical samples by multiplex reverse transcription nested-PCR assay. J Med Virol 2003 Jan;69(1):132-44
Coker R, Mounier-Jack S. Pandemic influenza preparedness in the Asia-Pacific region. Lancet 2006 (Published online Aug 22)
Coker R. UK preparedness for pandemic influenza. BMJ 2007 May 12;334(7601):965
Coleman CH, Reis A. Potential penalties for health care professionals who refuse to work during a pandemic. (Commentary) JAMA 2008 Mar 26;299(12):1471-3
Colina R, Costa-Mattioli M, Dowling RJO, et al. Translational control of the innate immune response through IRF-7. Nature 2008 Mar 20;452(7185):323-8 (published online Feb 13)
Colizza V, Barrat A, Barthelemy M, et al. Modeling the worldwide spread of pandemic influenza: Baseline case and containment interventions. PLoS Med 2007 Jan 23;4(1):e13
Colizza V, Barrat A, Barthelemy M, et al. The role of the airline transportation network in the prediction and predictability of global epidemics. Proc Natl Acad Sci 2006 (published online Feb 3)
Collignon PJ, Carnie JA. Infection control and pandemic influenza. Med J Aust 2006 Nov 20;185(10 suppl):S54-7
Collins N, Litt J, Moore M, et al. General practice: professional preparation for a pandemic. Med J Aust 2006 Nov 20;185(10 suppl):S66-9
Conenello GM, Palese P. Influenza A virus PB1-F2: a small protein with a big punch. (Editorial) Cell Host Microbe 2007 Oct 10;2(4):207-9
Conenello GM, Zamarin D, Perrone LA, et al. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 2007 Oct 5;3(10):e141
Conly JM. Personal protective equipment for preventing respiratory infections: What have we really learned? (Commentary) CMAJ 2006 Aug 1;175(3):263-4
Cooper B. Influenza pandemic scenario analysis report: could a pandemic be contained using antiviral agents? Eurosurveillance Weekly 2004 May 6;8(19)
Cooper BS, Pitman RJ, Edmunds WJ, et al. Delaying the international spread of pandemic influenza. PLoS 2006 Jun;3(6)
Cox NJ, Subbarao K. Global epidemiology of influenza: past and present. Annu Rev Med 2000 Feb;51:407-21
Cox NJ, Tamblyn SE, Tam T. Influenza pandemic planning. Vaccine 2003 May 1;21(16):1801-3
Crawford PC, Dubovi EJ, Castleman WL, et al. Transmission of equine influenza virus to dogs. Science 2005 Oct 21;310(5747):482-5
CRS (Congressional Research Service). Pandemic influenza: an analysis of state preparedness and response plans. Released Sep 24, 2007
CSTE. Influenza preparedness state plans
Cummings KJ, Cox-Ganser J, Riggs MA, et al. Respirator donning in post-hurricane New Orleans. Emerg Infect Dis 2007 May;13(5) (published online Mar 30)
Cunha BA. Influenza: historical aspects of epidemics and pandemics. Infect Dis Clin North Am 2004 Mar;18(1):141-5
Curran MS, Ellis JS, Wreghitt TG, et al. Establishment of a UK National Influenza H5 Laboratory Network. J Med Microbiol 2007 Oct;56(10):1263-7
Davey VJ, Glass RJ. Rescinding community mitigation strategies in an influenza pandemic. Emerg Infect Dis 2008 Mar;14(3) (published online Feb 4)
Dawes M. Using physical barriers to reduce the spread of respiratory viruses. (Editorial) BMJ 2008 Jan 12;336(7635):55-6
De Clercq E. Antiviral agents active against influenza A viruses. Nature Rev Drug Disc 2006 Dec;5(12):1015-25
De Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. (Letter) Nat Med 2006 Oct:12(10):1203-7
De Jong MD, Thanh TT, Khank TH, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 2005 Dec 22;353(24):2667-72
de Zwart O, Veldhuijzen IK, Elam G, et al. Avian influenza risk perception, Europe and Asia. Emerg Infect Dis 2007 Feb;13(2) (published online Jan 10)
Debarre F, Bonhoeffer S, Regoes RR. The effect of population structure on the emergence of drug resistance during influenza pandemics. J R Soc Interface 2007 Oct 22;4(16):893-906
Democratis J, Pareek M, Stephenson I. Use of neuraminidase inhibitors to combat pandemic influenza. J Antimicrob Chemother 2006 (published online Sep 6)
Department of Health & Children (Ireland). Influenza Pandemic Preparedness in Ireland Joint Assessment Report 2007. Released Nov 26
Department of Health (UK). Exercise Winter Willow: lessons identified. Aug 30, 2007
Department of Health (UK). Links to reports on UK's national plan, including guidance for hospitals, ambulance services, primary care, and adult social care as well as ethical considerations, released Nov 22
Department of Health (UK). Pandemic flu: a national framework for responding to an influenza pandemic. Released Nov 22, 2007
Department of Health (UK). Responding to pandemic influenza: the ethical framework for policy and planning. Released Nov 22, 2007
Department of the Treasury (US), FBIIC, FSSCC, et al. The FBIIC/FSSCC pandemic flu exercise of 2007 after action report. Released Jan 24, 2008
Devereaux A, Christian MC, Dichter JR, et al. Summary of suggestions from the Task Force for Mass Critical Care Summit, January 26-27, 2007. Chest 2008 May;133(5 suppl):S1-7
DHS. Creating a culture of preparedness among schools. Released Oct 30, 2007
DHS. National infrastructure protection plan. Released Jun 30, 2006
DHS. National preparedness guidelines. Released Sep 13, 2007
DHS. Nationwide plan review phase 2 report. Jun 16, 2006
DiNapoli JM, Yang L, Suguitan A Jr, et al. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza. J Virol 2007 Nov;81(21):11560-8
Dinh PN, Long HT, Tien NTK, et al. Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerg Infect Dis 2006;12(12) (published online Oct 25)
DoD (Dept of Defense). Pandemic influenza: clinical guidelines for the military health system. Released May 17, 2007
DoD. Department of Defense implementation plan for pandemic influenza. Released May 9, 2007
Dolin R. Influenza: interpandemic as well as pandemic disease. (Perspective) N Engl J Med 2005 Dec 15;353(24):2535-7
Doolittle A. Ill prepared: pandemic flu could cripple government. Federal Times 2007 Oct 15
DOT (US Department of Transportation). Sub-sector pandemic influenza planning guidelines (for aviation, highway and motor carrier, maritime, mass transit, and railroad sub-sectors). Released Apr 1, 2008, as annexes to DHS preparedness guidelines
Dowdle WR. Influenza pandemic periodicity, virus recycling, and the art of risk assessment. Emerg Infect Dis 2006 Jan;12(1):34-9
Du QS, Wang SQ, Chou KC. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus. Biochem Biophys Res Comm 2007 (published online Aug 13)
Duerr HP, Brockmann SO, Piechotowski I, et al. Influenza pandemic intervention planning using InfluSim: pharmaceutical and non-pharmaceutical interventions. BMC Infect Dis 2007;7:76 (published online Jul 13)
Dwyer DE, Smith DW, Catton MG, et al. Laboratory diagnosis of human seasonal and pandemic influenza virus infection. Med J Aust 2006 Nov 20;185(10 suppl):S48-53
Eisenman DP, Cordasco KM, Asch S, et al. Disaster planning and risk communication with vulnerable communities: lessons from Hurricane Katrina. Am J Public Health 2007 (published online Apr 5)
Emanuel E, Wertheimer A. Public health: who should get influenza vaccine when not all can? Science 2006 May 12;312(5775):854-5
Enserink M. Influenza: tense meeting produces some hope for flu-sharing deal. Science 2007 Nov 30;318(5855):1361
Epico working group. Modelling scenarios of diffusion and control of pandemic influenza, Italy. Eurosurveillance Weekly 2007 Jan 4;12(1):E070104.2
Epstein JM, Goedecke DM, Yu F, et al. Controlling pandemic flu: the value of international air travel restrictions. PLoS One 2007 May;2(5):e401
Epstein SL. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis 2006 Jan 1;193(1):49-53
European Centre for Disease Prevention and Control (ECDC). Technical report: Expert advisory groups on human H5N1 vaccines: public health and operational questions. Released Sep 20, 2007
European Centre for Disease Prevention and Control (ECDC). Technical report: Expert advisory groups on human H5N1 vaccines: scientific questions. Released Sep 20, 2007
European Centre for Disease Prevention and Control (ECDC). Technical report: pandemic influenza preparedness in the EU. Released Feb 22, 2007
European Centre for Disease Surveillance and Control. Highly pathogenic avian influenza A/H5N1--update and overview of 2006. Eurosurveillance Weekly 2006 Dec 21;11(12):E061221.1
European Commission. Influenza and how the EU should respond to a pandemic. Press release, Mar 31, 2004
European Commission. Timeline of actions by the EC on avian influenza and human flu pandemic preparedness. Aug 25, 2005
Eurosurveillance Editorial Team, Paget J. Considerable progress in European preparations for a potential influenza pandemic. Eurosurveillance Weekly 2004 Dec 23;8(52)
FAO. Bird flu virus in Europe--a hidden danger. Oct 25, 2007, release
FAO. Enhancing control of highly pathogenic avian influenza in developing countries through compensation: issues and good practice. Nov 27, 2006
FAO. Potential risk of highly pathogenic avian influenza (HPAI) spreading through wild water bird migration. FAOAIDEnews 2005 Sep 1;33
FAO. Update on the avian influenza situation. AIDE News 2006 Jun 19, Issue no. 40
Fasina FO, Bisschop SP, Webster RG. Avian influenza H5N1 in Africa: an epidemiological twist. Lancet Infect Dis 2007 Nov;7(11):696-7
Fauci AS. Pandemic influenza threat and preparedness. Emerg Infect Dis 2006 Jan;12(1):73-7
Fauci AS. Seasonal and pandemic influenza preparedness: science and countermeasures. J Infect Dis 2006 Nov 1;194(suppl 2):S73-6
FDA. FDA approves first U.S. vaccine for humans against the avian influenza virus H5N1. Apr 17, 2007, press release
FDA. FDA clears first respirators for use in public health medical emergencies. May 8, 2007, news release
FDA. FDA pandemic influenza preparedness strategic plan. Released Mar 14, 2007
FDA. Guidance for industry: clinical data needed to support the licensure of pandemic influenza vaccines. May 31, 2007
Fedson DS, Dunnill P. New approaches to confronting an imminent influenza pandemic. (Commentary) Perm J 2007 summer;11(3):63-9
Fedson DS. Confronting an influenza pandemic with inexpensive generic agents: can it be done? Lancet Infect Dis 2008 (published online Apr 16)
Fedson DS. Pandemic influenza and the global vaccine supply. Clin Infect Dis 2003 Jun 15;36(12):1552-61
Fedson DS. Pandemic influenza: a potential role for statins in treatment and prophylaxis. (Viewpoints) Clin Infect Dis 43(2):199-205
Fedson DS. Vaccination for pandemic influenza and severe acute respiratory syndrome: common issues and concerns. (Editorial Commentary) Clin Infect Dis 2003 Jun 15;36(12):1562-3
Fedson DS. Vaccination for pandemic influenza: a six point agenda for interpandemic years. Pediatr Infect Dis J 2004 Jan;23(1 Suppl):S74-7
Fell G. Preparedness of residential and nursing homes for pandemic flu. J Public Health 2008 Mar;30(1):99-102
Ferguson N. Poverty, death, and a future influenza pandemic. Lancet 2006 Dec 23;368(9554);2187-8
Ferguson NM, Cummings DA, Fraser C, et al. Strategies for mitigating an influenza pandemic. (Letter) Nature 2006 (published online Apr 26)
Ferguson NM, Cummings DAT, Cauchemez S, et al. Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 2005 Sep 8;437:209-14
Fick J, Lindberg RH, Tysklind M, et al. Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virus. PLoS ONE 2007 Oct 3;2(10):e986
Fidler D. Influenza virus samples, international law, and global health diplomacy. Emerg Infect Dis 2008 Jan;14(1):88-94
Finkelstein DB, Mukatira S, Mehta PK, et al. Persistent host markers in pandemic and H5N1 influenza viruses. J Virol 2007 (published online Jul 25)
Florida Dept of Agriculture & Consumer Services. Pandemic influenza: agriculture planning toolkit. Released Apr 28, 2008
Forsberg White L, Pagano M. Transmissibility of the influenza virus in the 1918 pandemic. PLoS ONE 2008 Jan 30;3(1):e1498
Fouchier RAM, Munster V, Wallensten A, et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 2005 Mar;79(5):2814-22
Fraser C. Influenza pandemic vaccines: spread them thin? PLoS Med 2007 Jun;4(6):e228
FSSCC (Financial Services Sector Coordinating Council for Critical Infrastructure Protection and Homeland Security). Statement on preparations for "avian flu." Jan 24, 2006
Gambotto A, Barrat-Boyes SM, de Jong MD, et al. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008 Apr 25;371(9622):1464-75
Gani R, Hughes H, Fleming D, et al. Potential impact of antiviral use on hospitalizations during influenza pandemic. Emerg Infect Dis 2005 Sep;11(9)
GAO (US Government Accountability Office). Financial market preparedness: significant progress has been made, but pandemic planning and other challenges remain. Report released May 1, 2007
GAO (US Government Accountability Office). Homeland Security: observations on DHS and FEMA efforts to prepare for and respond to major and catastrophic disasters and address related recommendations and legislation. GAO-07-1142T. Jul 31, 2007
GAO (US Government Accountability Office). Influenza pandemic: DOD combatant commands' preparedness efforts could benefit from more clearly defined roles, resources, and risk mitigation. GAO-07-696. Jul 20, 2007
GAO (US Government Accountability Office). Influenza pandemic: efforts to forestall onset are under way; identifying countries at greatest risk entails challenges. Released Jun 20, 2007
GAO (US Government Accountability Office). Influenza pandemic: efforts under way to address constraints on using antivirals and vaccines to forestall a pandemic. GAO-08-92. Released Jan 22, 2008 (but dated Dec 21, 2007)
GAO (US Government Accountability Office). Influenza pandemic: federal executive boards' ability to contribute to pandemic preparedness. Senate testimony Sep 28, 2007
GAO (US Government Accountability Office). Influenza pandemic: further efforts are needed to ensure clearer federal leadership roles and an effective national strategy. GAO-07-781. August 14, 2007
GAO (US Government Accountability Office). Influenza pandemic: opportunities exist to address critical infrastructure protection challenges that require federal and private sector coordination. GAO-08-36. Released Oct 31, 2007
GAO (US Government Accountability Office). Influenza pandemic: opportunities exist to clarify federal leadership roles and improve pandemic planning. Testimony before the Subcommittee on Emerging Threats, Cybersecurity, and Science and Technology, House Committee on Homeland Security. GAO-07-1257T. September 26, 2007
Gao W, Soloff AD, Lu X, et al. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol 2006 Feb;80(4):1959-64
Garcia-Sastre A, Whitley RJ. Lessons learned from reconstructing the 1918 influenza pandemic. J Infect Dis 2006 Nov 1;194(suppl 2):S127-32
Garcia-Sastre A. Antiviral response in pandemic influenza viruses. Emerg Infec Dis 2006 Jan;12(1):44-7
Garrett L, Fidler DP. Sharing H5N1 viruses to stop a global influenza pandemic. (Commentary) PLoS Med 2007 (published online Nov 20)
Garrett L. The next pandemic? Foreign Aff 2005 Jul/Aug;84(4)
Garrett TA. Pandemic economics: the 1918 influenza and its modern-day implications. Review (Federal Reserve Bank of St Louis) 2008 Mar/Apr;90(2):74-94
Gatrad AR, Shafi S, Memish ZA, et al. Hajj and the risk of influenza (Editorial). BMJ 2006 Dec 9;333(7580):1182-3
Gayer M, Watson JT, Connolly MA. Displaced populations and pandemic influenza. Lancet Infect Dis 2006 Dec;6(12):755-6
Ge J, Deng D, Wen Z, et al. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 2007 Jan;81(1):150-8
Gensheimer KF, Fukuda K, Brammer L, et al. Preparing for pandemic influenza: the need for enhanced surveillance. Vaccine 2002 May 15;20 Suppl 2:S63-
Gerberding JL. Pandemic preparedness: pigs, poultry, and people versus plans, products, and practice. J Infect Dis 2006 Nov 1;194(suppl 2):S77-81
Germann TC, Kadau K, Longini IM Jr, et al. Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci 2006 Apr 11;103(15):5935-40
Germann TC, Kadau K, Longini IR, et al. Mitigation strategies for pandemic influenza in the United States. Proc Natl Acad Sci 2006 (published online Apr 3)
Ghedin E, Sengamalay NA, Shumway M, et al. Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature 2005 Oct 20;437(7062):1162-6
Giacomet V, Tarallo L, De Marco G, et al. Preparing for an influenza pandemic in Italy: resources and procedures in paediatric hospital units. Eurosurveillance Monthly 2007 Jul-Aug;12(7-8) (published online Aug 10)
Gilsdorf A, Boxall N, Gasimov B, et al. Two clusters of human infection with influenza A/H5N1 virus in the Republic of Azerbaijan, February-March 2006. Eurosurveillance Monthly 2006 May;11(5)
Glass K, Barnes B. How much would closing schools reduce transmission during an influenza pandemic? Epidemiology 2007 Sep;18(5):623-8
Glass LM, Glass RJ. Social contact networks for the spread of pandemic influenza in children and teenagers. BMC Public Health 2008;8:61 (published online Feb 14)
Glass RJ, Glass LM, Beyeler WE. Targeted social distancing design for pandemic influenza. Emerg Infect Dis 2006 Nov;12(11) (published online Oct 6)
Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996;18(1):64-76
Goldrick BA, Goetz AM. Pandemic influenza: what infection control professionals should know. Am J Infect Control 2007 Feb;35(1):7-13
Gostin L. Public health strategies for pandemic influenza. (Commentary) JAMA 2006 Apr 12;295(14):1700-4
Gostin LO. Medical countermeasures for pandemic influenza: ethics and the law. JAMA 2006 Feb 1;295(5):554-6
Govorkova EA, Webby RJ, Humberd J, et al. Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J Infect Dis 2006 Jul 15;194(2):159-67
Grais RF, Ellis JH, Glass GE. Assessing the impact of airline travel on the geographic spread of pandemic influenza. Eur J Epidemiol 2003;18(11):1065-72
Gray GC, Baker WS. The importance of including swine and poultry workers in influenza vaccination programs. Clin Pharmacol Ther 2007 Dec;82(6):638-41
Gray GC, Trampel DW, Roth JA. Pandemic influenza planning: Shouldn't swine and poultry workers be included? Vaccine 2007 May 30;25(22):4376-81
Green MD, Nettey H, Wirtz RA. Determination of oseltamivir quality by colorimetric and liquid chromatographic methods. Emerg Infect Dis 2008 Apr (published online Mar 5)
Gronvall GK, Borio LL. Removing barriers to global pandemic influenza vaccination. Biosec Bioterr 2006 Jun;4(2):168-75
Gronvall GK, Smith BT, Matheny J, et al. Biomedical Advanced Research and Development Authority (BARDA) roundtable. Biosecur Bioterror 2007 Jun;5(2):174-9
Gross PA. Preparing for the next influenza pandemic: a reemerging infection. Ann Intern Med 1996;124(7):682-5
Grotto AJ, Tucker JB. Biosecurity: a comprehensive action plan. Center for American Progress. Jun 2006
Gu J, Xie Z, Gao Z, et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 2007 Sep 29;370(9593):1137-45
Guan Y, Chen H, Li KS, et al. A model to control the epidemic of H5N1 influenza at the source. BMC Infect Dis 2007;7:132 (published online Nov 13)
Guan Y, Poon LLM, Cheung CY, et al. H5N1 influenza: a protean pandemic threat. Proc Natl Acad Sci 2004 May 25;101(21):8156-61
Gumel AB, Nuno M, Chowell G. Mathematical assessment of Canada's pandemic influenza preparedness plan. Can J Infect Dis Med Microbiol 2008 Mar/Apr;19(2):185-92
Guralnik M, Rosenbloom RA, Petteruti MP, et al. Limitations of current prophylaxis against influenza virus infection. Am J Ther 2007 Sep-Oct;14(5):449-54
Gursky EA, Joint Task Force Civil Support Mass Fatality Working Group. A working group consensus statement on mass-fatality planning for pandemics and disasters. J Homeland Secur 2007 Jul 6
Gust ID, Hampson AW, Lavanchy D. Planning for the next pandemic of influenza. Rev Med Virol 2001 Jan-Feb;11(1):59-70
Haber MJ, Shay DK, Davis XM, et al. Effectiveness of interventions to reduce contact rates during a simulated influenza pandemic. Emerg Infect Dis 2007 Apr;13(4) (published online Mar 5)
Hall IM, Gani R, Hughes HE, et al. Real-time epidemic forecasting for pandemic influenza. Epidemiol Infect 2006, published online Aug 24
Halloran ME, Ferguson NM, Eubank S, et al. Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci 2008 (published online Mar 10)
Hampson AW, Mackenzie JS. The influenza viruses. Med J Aust 2006 Nov 20;185(10 suppl):S39-43
Hampson AW. Ferrets and the challenges of H5N1 vaccine formulation. (Commentary) J Infect Dis 2006 Jul 15;194(2):143-5
Hampson AW. Surveillance for pandemic influenza. J Infect Dis 1997 Aug;176(Suppl 1):S8-13
Handel A, Longini IM Jr, Antia R. Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread. PLoS Comp Biol 2007 Dec 7;3(12):e240
Hanson BJ, Boon AC, Lim AP, et al. Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice. Respiratory Res 2006;7:126 (published online Oct 14)
Haque A, Hober D, Kasper LH. Confronting potential influenza A (H5N1) pandemic with better vaccines. Emerg Infect Dis 2007 Oct;13(10):1512-8
Harrod ME, Emery E, Dwyer DE. Antivirals in the management of an influenza pandemic. Med J Aust 2006 Nov 20;185(10 suppl):S58-61
Hatchett RJ, Mecher CE, Lipsitch M. Public health interventions and epidemic intensity during the 1918 influenza pandemic. Proc Natl Acad Sci 2007 (published online Apr 6)
Hatta M, Hatta Y, Kim JH, et al. Growth of H5N1 influenza A viruses in the upper respiratory tract of mice. PLoS Pathog 2007 Oct 5;3(10):e133
Hatta M, Kawaoka Y. The continued pandemic threat posed by avian influenza viruses in Hong Kong. Trends Microbiol 2002 Jul;10(7):340-4
Haug A, Brand-Miller JC, Christophersen OA, et al. A food "lifeboat": food and nutrition considerations in the event of a pandemic or other catastrophe. Med J Aust 2007 Dec 3/17;187(11/12):674-6
Hayden F, Croisier A. Transmission of avian influenza viruses to and between humans. (Commentary) J Infect Dis 2005 Oct 15;192(8):1311-4
Hayden FG, Cote KM, Douglas RG Jr. Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob Agents Chemother 1980 May;17(5):865-70
Hayden FG, Palese P. Influenza virus. In: Richman DD, Whitley RJ, Hayden FG, eds. Clinical virology. Ed. 2. Washington, DC: ASM Press, 2002
Hayden FG, Pavia AT. Antiviral management of seasonal and pandemic influenza. J Infect Dis 2006 Nov 1;194(suppl 2):S119-26
Hayes HB. DHS offers advice for ensuring telecom during pandemic. Gov Health IT 2008 (published online Jan 1)
Heiny AT, Miotto O, Srinivasan KN, et al. Evolutionarily conserved protein sequences of influenza A viruses, avian and human, as vaccine targets. PLoS ONE 2007 Nov 21;2(11):e1190
Henle W, Henle G, Stokes J, et al. Experimental exposure of human subjects to viruses of influenza. J Immunol 1946;52:145-65
Herman B, Rosychuk RJ, Bailey T, et al. Medical students and pandemic influenza. Emerg Infect Dis 2007 Nov;13(11):1781-3
Herrmann B, Larsson C, Zweygberg BW. Simultaneous detection and typing of influenza viruses A and B by a nested reverse transcription-PCR: comparison to virus isolation and antigen detection by immunofluorescence and optical immunoassay (FLU OIA). J Clin Microbiol 2001 Jan;39(1):134-8
HHS Agency for Healthcare Research and Quality. Adapting community call centers for crisis support: a model for home-based care and monitoring. Oct 26, 2007
HHS Agency for Healthcare Research and Quality. Emergency preparedness atlas: US nursing home and hospital facilities. Released Jul 19, 2007
HHS Agency for Healthcare Research and Quality. Nursing homes in public health emergencies: special needs and potential roles. Released Jul 19, 2007
HHS. Correctional facilities pandemic influenza planning checklist. Released Sep 21, 2007
HHS. Draft guidance on allocating and targeting pandemic influenza vaccine. Released Oct 23, 2007
HHS. HIPAA privacy rule: disclosures for emergency preparedness - a decision tool. Released Jul 5, 2006
HHS. Influenza pandemics: how they start, how they spread, and their potential impact. National Vaccine Program Office
HHS. Interim guidance on planning for the use of surgical masks and respirators in health care settings during an influenza pandemic. Oct 17, 2006
HHS. Law enforcement pandemic influenza planning checklist. Released Sep 21, 2007
HHS. Pandemic and All-Hazards Preparedness Act progress report. Released Oct 31, 2007
HHS. Pandemic influenza implementation plan. Released Dec 18, 2006
HHS. Pandemic influenza plan. Released Nov 2, 2005
HHS. Pandemic influenza planning: a guide for individuals and families. Jan 2006
HHS. Pandemic planning update II. A report from Secretary Michael O. Leavitt. Jun 29, 2006
HHS. Pandemic planning update III: a report from Secretary Michael O. Leavitt. Nov 13, 2006
HHS. Pandemic planning update IV: a report from Secretary Michael O. Leavitt. Jul 18, 2007
HHS. Pandemic planning update: a report from Secretary Michael O. Leavitt. Mar 13, 2006
HHS. Pandemic update V: a report from Secretary Michael O. Leavitt. Mar 17, 2008
HHS. PandemicFlu.gov
HHS. Tabletop exercises for pandemic influenza preparedness in local public health agencies. Dec 5, 2006
HHS. Transcript of press briefing on the US government's HHS Pandemic Influenza Plan. Nov 2, 2005
Hick JL, O'Laughlin DT. Concept of operations for triage of mechanical ventilation in an epidemic. Acad Emerg Med 2006 Feb;13(2):223-9
Hien TT, de Jong M, Farrar J. Avian influenza: a challenge to global health care structures. N Engl J Med 2004 Dec 2;351(23):2363-5
Higgs ES, Hayden FG, Chotpitayasunondh T, et al. The Southeast Asian Influenza Clinical Research Network: development and challenges for a new multilateral research endeavor. Antiviral Res 2008 Apr;78(1):64-68
Hodge JG Jr, Gostin LO, Vernick JS. The Pandemic and All-Hazards Preparedness Act: improving public health emergency response. (Commentary) JAMA 2007 Apr 18;297(15):1708-11
Hoelscher MA, Jayashankar L, Garg s, et al. New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice. Clin Pharmacol Ther 2007 Dec;82(6):665-71
Hoelscher MA, Singh N, Garg S, et al. A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses. J Infect Dis 2008 (published online Mar 18)
Hoffman DR, Nannini A. Planning, surveillance, and reporting for pandemic influenza: a briefing for advance practice nurses. J Am Acad Nurse Pract 2008 Jan;20(1):11-6
Hollingsworth TD, Ferguson NM, Anderson RM. Frequent travelers and rate of spread of epidemics. Emerg Infect Dis 2007 Sep;13(9):1288-94
Holman DH, Wang D, Raja NU, et al. Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses. Vaccine 2008 May 19;26(21):2627-39
Holmberg SD, Layton CJ, Ghneim G, et al. State plans for containment of pandemic influenza. Emerg Infect Dis 2006 Sep;12(9)
Hom GG, Chous AP. The prospect of pandemic influenza: why should the optometrist be concerned about a public health problem? Optometry 2007 Dec;78(12):629-43
Home Office (UK). Planning for a possible influenza pandemic: a framework for planners preparing to manage deaths. Aug 30, 2007
Horimoto T, Kawaoka Y. Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev 2001 Jan;14(1):129-49
Horimoto T, Murakami S, Muramoto Y, et al. Enhanced growth of seed viruses for H5N1 influenza vaccines. Virology 2007 Sep 15;366(1):23-7
Horstick O, Kaiser R, Ciotti M, et al. Europe makes progress in preparing for influenza pandemic, but further work needed. Eurosurveillance Weekly 2005 Nov 17;10(11)
Horvath JS, McKinnon M, Roberts L. The Australian response: pandemic influenza preparedness. Med J Aust 2006 Nov 20;185(10 suppl):S35-8
Hsieh YH, Cheng YS. Real-time forecast of multiphase outbreak. Emerg Infect Dis 2006 Jan;12(1)
Hulse-Post DJ, Sturm-Ramirez KM, Humberd J, et al. Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci 2005 Jul 26;102(30)
Ichinohe T, Tamura SI, Kawaguchi A, et al. Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine. J Infect Dis 2007 Nov 1;196(9):1313-20
IDSA (Infectious Diseases Society of America). Detailed comments on the core document and annexes of the HHS pandemic preparedness and response plan. Oct 26, 2004
IDSA (Infectious Diseases Society of America). Pandemic and seasonal influenza principles for US action. Released Jan 25, 2007
India Press Information Bureau. A vison and road map. Document released at the close of 3-day international conference on avian flu. Dec 6, 2007
Influenza team, ECDPC. Influenza transmission: research needs for informing infection control policies and practice. Eurosurveillance Weekly 2007 May 10;12(5):E070510.1
Inglesby TV, Nuzzo JB, O'Toole T, et al. Disease mitigation measures in the control of pandemic influenza. Biosecurity Bioterrorism 2006 Dec;4(4)
IOM (Institute of Medicine). Antivirals for pandemic influenza: guidance on developing a distribution and dispensing program. Released Apr 25, 2008
IOM (Institute of Medicine). Modeling community containment for pandemic influenza: a letter report. Released Dec 11, 2006
IOM (Institute of Medicine). Preparing for an influenza pandemic: personal protective equipment for healthcare workers. Sep 18, 2007
IOM (Institute of Medicine). Research priorities in emergency preparedness and response for public health systems: a letter report. Jan 22, 2008
IOM (Institute of Medicine). Review of the DoD-GEIS influenza programs: strengthening global surveillance and response. Sep 25, 2007
IOM (Institute of Medicine). The threat of pandemic influenza: are we ready? 2005
IOM. Hospital-based emergency care: at the breaking point. Prepublication proof. Jun 14, 2006
IOM. Reusability of facemasks during an influenza pandemic: facing the flu. Apr 27, 2006
Ip M, Tang JW, Hui DSC, et al. Airflow and droplet spreading around oxygen masks: a simulation model for infection control research. Am J Infect Control 2007 Dec;35(10):684-9
Irish Council for Bioethics. Ethical dilemmas in a pandemic: proceedings of the Irish Council for Bioethics Conference, 17th October 2006, Dublin. Released Aug 22, 2007
Irvin C, Cindrich L, Patterson W, et al. Hospital personnel response during a hypothetical influenza pandemic: will they come to work? Acad Emerg Med 2007 May;14(5 suppl 1):S13
Itzwerth RL, MacIntyre CR, Shah S, et al. Pandemic influenza and critical infrastructure dependencies: possible impact on hospitals. Med J Aust 2006 Nov 20;185(10 suppl):S70-2
Jadhao SJ, Achenbach J, Swayne DE, et al. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine. Vaccine 2008 Mar 25;26(14):1742-50
Jefferson T, Demicheli V, Rivetti D, et al. Antivirals for influenza in healthy adults: systematic review. Lancet 2006 Jan 28;367(9507):303-13
Jefferson T, Foxlee R, Del Mar C, et al. Interventions for the interruption or reduction of the spread of respiratory viruses. Cochrane Database Syst Rev 2007 Oct 17;(4):CD006207
Jefferson T, Foxlee R, Del Mar C, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ 2008 Jan 12;336(7635):77-80
Johansson BE, Brett IC. Changing perspective on immunization against influenza. Vaccine 2007 Apr 20;25(16):3062-5
Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull Hist Med 2002 Spring;76(1):105-15
Jones DA, Nozick LK, Turnquist MA, et al. Pandemic influenza, worker absenteeism and impacts on freight transportation. Proc 41st Hawaii Intl Conf Syst Sci 2008 (published online Apr 9)
Jones JC, Turpin EA, Bultmann H, et al. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. J Virol 2006 Dec;80(24):11960-7
Jones JC, Turpin EA, Bultmann H, et al. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. J Virol 2006, published online Sep 27
Kahn LH. Pandemic influenza school closure policies. (Letter) Emerg Infect Dis 2007 Feb;13(2) (published online Jan 5)
Kaiser R, Coulombier D, Baldari M, et al. What is epidemic intelligence, and how is it being improved in Europe? Eurosurveillance Weekly 2006 Feb 2;11(2)
Kaiser R, Coulombier D. Epidemic intelligence during mass gatherings. Eurosurveillance Weekly 2006 Dec 21;11(12):E061221.3
Kaji AH, Lewis RJ. Hospital disaster preparedness in Los Angeles County. Acad Emerg Med 2006 (published online Aug 2)
Kamps BS, Hoffmann C, Preiser W, eds. Influenza report 2006. Paris, Cagliar, Wuppertal, Sevilla: Flying Publisher, 2006. 225 pp
Kandun IN, Wibisono H, Sedyaningsih ER, et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 2006 Nov 23;355(21):2186-94
Kash JC, Tumpey TM, Proll SC, et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 2006 Oct5;443(7111):578-81
Katz A, Staiti AB, McKenzie KL. Preparing for the unknown, responding to the known: communities and public health preparedness. Health Aff 2006 Jul/Aug;25(4):946-57
Kawana A, Naka G, Fujikura Y, et al. Spanish influenza in Japanese armed forces, 1918-1920. Emerg Infect Dis 2007 Apr;13(4) (published online Mar 5)
Keawcharoen J, Oraveerakul K, Kuiken T, et al. Avian influenza H5N1 in tigers and leopards. Emerg Infect Dis 2004 Dec;10(12)
Kelen GD, Kraus CK, McCarthy ML, et al. Inpatient disposition classification for the creation of hospital surge capacity: a multiphase study. Lancet 2006 Dec 2;368(9551):1984-90
Kerneis S, Grais RF, Boelle PY, et al. Does the effectiveness of control measures depend on the influenza pandemic profile? PLoS ONE 2008 Jan 23;3(1):e1478
Kessler N, Ferraris O, Palmer K, et al. Use of the DNA flow-thru chip, a three-dimensional biochip, for typing and subtyping of influenza viruses. J Clin Microbiol 2004 May;42(5):2173-85
Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infec Dis 2006 Jan;12(1):9-14
Kilbourne ED. Influenza pandemics: can we prepare for the unpredictable? Viral Immunol 2004;17(3):350-7
Kilpatrick AM, Chmura AA, Gibbons DW, et al. Predicting the global spread of H5N1 avian influenza. Proc Natl Acad Sci 2006 (published online Dec 7)
Kleinman AM, Bloom BR, Saich A, et al. Avian and pandemic influenza: a biosocial approach. J Infect Dis 2008 Feb 15;197(S1):S1-S3
Klempner MS, Shapiro DS. Crossing the species barrier: one small step to man, one giant leap to mankind. (Perspective) N Engl J Med 2004 Mar 18;350(12):1171-2 (See also Hien above)
Kobasa D, Jones SM, Shinya K, et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007 Jan 18;445(7125):319-23
Kobasa D, Takada A, Shinya K, et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 2004 Oct 7;431(7009):703-7
Kochs G, Garcia-Sastre A, Martinez-Sobrido L. Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 2007 Jul;81(13):7011-21
Kong W-P, Hood C, Yang Z-Y, et al. Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination. Proc Natl Acad Sci 2006 (published online Oct 16)
Krause R. Swine flu and the fog of epidemics. Emerg Infec Dis 2006 Jan;12(1):40-3
Kreijtz JH, Bodewes R, van Amerongen G, et al. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice. Vaccine 2007 Jan 8;25(4):612-20
Kuntz JL, Holley S, Helms CM, et al. Use of a pandemic preparedness drill to increase rates of influenza vaccination among healthcare workers. Infect Control Hosp Epidemiol 2008 Feb;29(2):111-5
Lam C, Waldhorn R, Toner E, et al. The prospect of using alternative medical care facilities in an influenza pandemic. Biosecur Bioterror 2006 Dec;4(4):384-90
Larson RC. Simple models of influenza progression within a heterogeneous population. Oper Res 2007 May-Jun;55(3):399-412
Laver G, Garman E. Pandemic influenza: its origin and control. Microbes Infect 2002 Nov;4(13):1309-16
Le QM, Kiso M, Someya K, et al. Isolation of drug-resistant H5N1 virus. Nature 2005 Oct 20;437:1108
Leask J, Chapman S, Hawe P, et al. What maintains parental support for vaccination when challenged by anti-vaccination messages? A qualitative study. Vaccine 2006 Nov 30;4(49-50):7238-45
Lee VJ, Chen MI, Chan SP, et al. Influenza pandemics in Singapore, a tropical, globally connected city. Emerg Infect Dis 2007 Jul;13(7):1052-7
Lee VJ, Chen MI. Effectiveness of neuraminidase inhibitors for preventing staff absenteeism during pandemic influenza. Emerg Infect Dis 2007 Mar;13(3) (published online Feb 5)
Lee VJ, Phua KJ, Chen MI, et al. Economics of neuraminidase inhibitor stockpiling for pandemic influenza, Singapore. Emerg Infect Dis 2006 Jan;12(1)
Legastelois I, Garcia-Sastre A, Palese P, et al. Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells. Influenza Other Respir Virus 2007 (published online Jul 26)
Lemieux C, Brankston G, Gitterman L, et al. Questioning aerosol transmission of influenza. (Letter) Emerg Infect Dis 2007 Jan;13(1) (published online Dec 8)
Lemon SM, Hamburg MA, Sparling PF, et al. Ethical and Legal Considerations in Mitigating Pandemic Disease: Workshop Summary. Book from Board on Global Health and Institute of Medicine released Jun 11, 2007
Leroux-Roels I, Bernhard R, Gerard P, et al. Broad clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine. PLoS ONE 2008 Feb 27;3(2):e1665
Leroux-Roels K, Borkowski A, Vanwolleghem T, et al. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet 2007 Aug 18;370(9587):580-9
Levine R. A cure for the Asian flu. (Commentary) Biosecurity Bioterrorism 2006 Sep;4(3):228-30
Li KS, Guan Y, Wang J, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004 Jul 8;430:209-13
Li KS, Xu KM, Peiris JS, et al. Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans? J Virol 2003 Jun;77(12):6988-94
Li Z, Jiang Y, Jiao P, et al. The NS1 gene contributes to the virulence of H5N1 avian influenza virus. J Virol 2006 Nov;80(22):11115-23
Lien O, Franco C, Gronvall GK, et al. Getting medicine to millions in a public health emergency: can retailers play a role? From University of Pittsburgh Medical Center. 2005
Lien O, Maldin B, Franco C, et al. Getting medicine to millions: new strategies for mass distribution. Biosec Bioterr 2006 Jun;4(2):176-82
Lim WS, Thomson A, Little P. Preparing for the next flu pandemic (Editorial). BMJ 2007 Feb 10;334(7588):268-9
Lim WS. Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Thorax 2007 Jan;62(suppl 1):1-46
Lin J, Zhang J, Dong X, et al. Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial. Lancet 2006 (published online Sep 7)
Lindegardh N, Davies GR, Hien TT, et al. Importance of collection tube during clinical studies of oseltamivir. Antimicrob Agents Chemother 2007 May;51(5):1835-6
Lipatov AS, Webby RJ, Govorkova EA, et al. Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model. J Infect Dis 2005 Apr 15;191(8):1216-20
Lipsitch M, Cohen t, Murray M, et al. Antiviral resistance and the control of pandemic influenza. PLoS Med 2007 Jan 23;4(1):e15
Lofgren E, Fefferman NH, Naumov YN, et al. Influenza seasonality: underlying causes and modeling theories. J Virol 2007 Jun;81(11):5429-36
Longini IM Jr, Halloran ME, Nizam A, et al. Containing pandemic influenza with antiviral agents. Am J Epidemiol 2004 Apr 1;159(7):623-33
Longini IM, Nizam A, Xu S, et al. Containing pandemic influenza at the source. Science 2005 (published online Aug 3)
Look JL, Butler B, Al-Khalili M, et al. The adjuvant patch: a universal dose sparing approach for pandemic and conventional vaccines. BioPharm Int 2007 Aug (supp) (published online Aug 2)
Loosli CG, Lemon HM, Robertson OH, et al. Experimental airborne influenza infection. I. Influence of humidity on survival of virus in air. Proc Soc Exp Biol 1943; 53:205 6
Lovelace K, Bibeau D, Gansneder B, et al. All-hazards preparedness in an era of bioterrorism funding. J Public Health Manage Pract 2007 Sep/Oct;13(5):465-9
Low DE. Pandemic planning: non-pharmaceutical interventions. Respirology 2008 Mar;13(s1):S44-8
Lucio-Forster A, Bowman DD, Lucio-Martinez B, et al. Inactivation of the avian influenza virus (H5N2) in typical domestic wastewater and drinking water treatment systems. Environ Eng Sci 2006 Nov;23(6):897-903
Luk J, Gros
